236 related articles for article (PubMed ID: 18179912)
1. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability.
David TE; Feindel CM; Bos J; Ivanov J; Armstrong S
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):19-24. PubMed ID: 18179912
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of aortic valve replacement with the St. Jude Toronto stentless porcine valve.
Desai ND; Merin O; Cohen GN; Herman J; Mobilos S; Sever JY; Fremes SE; Goldman BS; Christakis GT
Ann Thorac Surg; 2004 Dec; 78(6):2076-83; discussion 2076-83. PubMed ID: 15561040
[TBL] [Abstract][Full Text] [Related]
3. Late results of heart valve replacement with the Hancock II bioprosthesis.
David TE; Ivanov J; Armstrong S; Feindel CM; Cohen G
J Thorac Cardiovasc Surg; 2001 Feb; 121(2):268-77. PubMed ID: 11174732
[TBL] [Abstract][Full Text] [Related]
4. Durability and prevalence of aortic regurgitation nine years after aortic valve replacement with the Toronto SPV stentless bioprosthesis.
Bach DS; Goldman B; Verrier E; Petracek M; Wood J; Goldman S; David TE;
J Heart Valve Dis; 2004 Jan; 13(1):64-72; discussion 72. PubMed ID: 14765842
[TBL] [Abstract][Full Text] [Related]
5. The Toronto SPV: hemodynamic data at 1 and 5 years' postimplantation.
Dellgren G; David TE; Raanani E; Bos J; Ivanov J; Rakowski H
Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):107-13. PubMed ID: 10660177
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hemodynamic performance of the Toronto SPV bioprosthesis.
Danton MH; Sarsam MA; Byrne JG; Campbell NS; Jones JM; Campalani G
J Heart Valve Dis; 2000 Sep; 9(5):644-52. PubMed ID: 11041179
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors as predictors of early and late survival after bioprosthetic valve replacement for aortic stenosis.
Le Tourneau T; Marechaux S; Vincentelli A; Ennezat PV; Modine T; Polge AS; Fayad G; Prat A; Warembourg H; Deklunder G
J Heart Valve Dis; 2007 Sep; 16(5):483-8. PubMed ID: 17944119
[TBL] [Abstract][Full Text] [Related]
8. The Stentless Cryo-Life O'Brien porcine aortic valve at 10 years.
Hvass U; Baron F; Elsebaey A; Nguyen D; Flecher E
J Heart Valve Dis; 2004 Nov; 13(6):977-83; discussion 983. PubMed ID: 15597593
[TBL] [Abstract][Full Text] [Related]
9. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients.
Aupart MR; Mirza A; Meurisse YA; Sirinelli AL; Neville PH; Marchand MA
J Heart Valve Dis; 2006 Nov; 15(6):768-75; discussion 775-6. PubMed ID: 17152784
[TBL] [Abstract][Full Text] [Related]
10. Stentless aortic valve reoperations: a surgical challenge.
Borger MA; Prasongsukarn K; Armstrong S; Feindel CM; David TE
Ann Thorac Surg; 2007 Sep; 84(3):737-43; discussion 743-4. PubMed ID: 17720369
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
[TBL] [Abstract][Full Text] [Related]
12. Prosthesis-patient mismatch after aortic valve replacement predominantly affects patients with preexisting left ventricular dysfunction: effect on survival, freedom from heart failure, and left ventricular mass regression.
Ruel M; Al-Faleh H; Kulik A; Chan KL; Mesana TG; Burwash IG
J Thorac Cardiovasc Surg; 2006 May; 131(5):1036-44. PubMed ID: 16678587
[TBL] [Abstract][Full Text] [Related]
13. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
14. Fifteen-year results with the Hancock II valve: a multicenter experience.
Rizzoli G; Mirone S; Ius P; Polesel E; Bottio T; Salvador L; Zussa C; Gerosa G; Valfrè C
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):602-9, 609.e1-4. PubMed ID: 16935116
[TBL] [Abstract][Full Text] [Related]
15. Operative risk of reoperative aortic valve replacement.
Potter DD; Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Schaff HV; Orszulak TA
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):94-103. PubMed ID: 15632830
[TBL] [Abstract][Full Text] [Related]
16. Freedom from structural valve deterioration among patients aged < or = 60 years undergoing Freestyle stentless aortic valve replacement.
Bach DS; Metras J; Doty JR; Yun KL; Dumesnil JG; Kon ND
J Heart Valve Dis; 2007 Nov; 16(6):649-55; discussion 656. PubMed ID: 18095515
[TBL] [Abstract][Full Text] [Related]
17. Aortic valve replacement with a stentless porcine bioprosthesis: multicentre trial. Canadian Investigators of the Toronto SPV Valve Trial.
Del Rizzo DF; Goldman BS; David TE
Can J Cardiol; 1995; 11(7):597-603. PubMed ID: 7656195
[TBL] [Abstract][Full Text] [Related]
18. Structural deterioration of the Freestyle aortic valve: mode of presentation and mechanisms.
Mohammadi S; Baillot R; Voisine P; Mathieu P; Dagenais F
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):401-6. PubMed ID: 16872969
[TBL] [Abstract][Full Text] [Related]
19. Eight-year results after aortic valve replacement with the CryoLife-O'Brien Stentless Aortic Porcine Bioprosthesis.
Martinovic I; Farah I; Everlien M; Lindemann S; Knez I; Wittlinger T; Greve H; Vogt P
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):777-82. PubMed ID: 16153928
[TBL] [Abstract][Full Text] [Related]
20. The Toronto SPV bioprosthesis: one-year results in 100 patients.
Mohr FW; Walther T; Baryalei M; Falk V; Autschbach R; Scheidt A; Dalichau H
Ann Thorac Surg; 1995 Jul; 60(1):171-5. PubMed ID: 7598582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
